Page last updated: 2024-08-25

uk 68798 and Complication, Postoperative

uk 68798 has been researched along with Complication, Postoperative in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burke, P; Khawaja, O; Machado, C; Sekulic, M; Serafimovski, N	1
Christiansen, EH; Christiansen, N; Frost, L; Mortensen, PE; Platou, ES; Tingleff, J	1
Sager, PT	1

Reviews

1 review(s) available for uk 68798 and Complication, Postoperative

Article	Year
New advances in class III antiarrhythmic drug therapy. Current opinion in cardiology, 1999, Volume: 14, Issue:1 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Denmark; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Postoperative Complications; Potassium Channel Blockers; Randomized Controlled Trials as Topic; Sulfonamides	1999

Trials

2 trial(s) available for uk 68798 and Complication, Postoperative

Article	Year
Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting. The American journal of cardiology, 2008, Jun-01, Volume: 101, Issue:11 Topics: Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Length of Stay; Male; Michigan; Phenethylamines; Postoperative Complications; Potassium Channel Blockers; Potassium Channels; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome	2008
Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group. International journal of cardiology, 1997, Jan-31, Volume: 58, Issue:2 Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Confidence Intervals; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenethylamines; Placebo Effect; Postoperative Complications; Sample Size; Sulfonamides; Treatment Outcome	1997

Article

Year

Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting.

The American journal of cardiology, 2008, Jun-01, Volume: 101, Issue:11

Topics: Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Length of Stay; Male; Michigan; Phenethylamines; Postoperative Complications; Potassium Channel Blockers; Potassium Channels; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome

2008

Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group.

International journal of cardiology, 1997, Jan-31, Volume: 58, Issue:2

Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Confidence Intervals; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenethylamines; Placebo Effect; Postoperative Complications; Sample Size; Sulfonamides; Treatment Outcome

1997